Connect with us
European Gaming Congress 2024

Artificial Intelligence

HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2023 Financial Results

Published

on

<!– Name:DistributionId Value:8790169 –> <!– Name:EnableQuoteCarouselOnPnr Value:False –> <!– Name:IcbCode Value:4530 –> <!– Name:CustomerId Value:500105856 –> <!– Name:HasMediaSnippet Value:false –> <!– Name:AnalyticsTrackingId Value:fec4a864-e5fa-467b-b0a9-a39b38454cb8 –>

Southlake, Texas, March 16, 2023 (GLOBE NEWSWIRE) — Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a medical technology company focused on saving lives by making an ECG (also known as an EKG) a more valuable screening tool through the use of Artificial Intelligence (AI), today provided a business update and reported financial results for the fiscal 2023 third quarter ended January 31, 2023.

Key Milestones during Fiscal Q3 2023 and to date:

  • Engaged in multi-year collaboration with Rutgers University to develop AI-based ECG algorithms
  • Further international patents granted, bringing total patent portfolio to 40 (nine U.S., 31 internationally)
  • Balance sheet strengthened through the amendment and exercise of pre-IPO bridge warrants, $15 million equity facility and extension of the maturity dates on investor loans
  • Appointed microcap veteran David R. Wells to Board of Directors

Andrew Simpson, Chief Executive Officer of HeartSciences, stated, “We continue to diligently work towards commercialization of the MyoVista®, with a key focus on our resubmission for FDA De Novo clearance.  The enrollment for our pivotal validation study is progressing and device testing is underway. In addition, as previously reported, we have also enrolled additional enrichment study patients to provide extra data and we continue to carefully manage our cash as we progress towards our goal of FDA De Novo resubmission in the current calendar year, assuming positive results.”

“We believe HeartSciences’ is at the leading edge of bringing new clinical capabilities to the ECG. The problem we’re seeking to solve is well known. Millions of people with heart disease remain undiagnosed until some sort of event that could have been preventable through early detection. That’s why our MyoVista® device is designed to significantly increase the clinical value of the ECG by detecting cardiac dysfunction at an early stage. Our objective is to become a fixture in front-line healthcare settings to help physicians make better and earlier referral decisions for at risk patients.”

The Company submitted its Form 10-Q to the SEC, which can be found here or on the Company’s website.  There were no meaningful revenues for the third quarter of 2023. As of January 31, 2022, cash and cash equivalents were $1.9 million. The Company continues to carefully manage its expenses and believes it has sufficient capital to support operations through resubmission for FDA De Novo clearance.

Advertisement

About HeartSciences

Heart Test Laboratories, Inc. d/b/a HeartSciences is a medical technology company focused on applying innovative AI-based technology to an ECG (also known as an EKG) to expand and improve an ECG’s clinical usefulness. Millions of ECGs are performed every week and the Company’s objective is to improve healthcare by making an ECG a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. HeartSciences’ first product candidate for FDA clearance, the MyoVista® wavECG, or the MyoVista®, is a resting 12-lead ECG that is also designed to provide diagnostic information related to cardiac dysfunction which has traditionally only been available through the use of cardiac imaging. The MyoVista® also provides conventional ECG information in the same test. The business model, which involves the use of the MyoVista® device and consumables for each test, is expected to be “razor-razorblade” as the electrodes used with the MyoVista® are proprietary to HeartSciences, and new electrodes are required for every test performed.
For more information, please visit: https://www.heartsciences.com. Twitter: @HeartSciences

Safe Harbor Statement

This announcement contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are made under the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and are relating to the Company’s future financial and operating performance. All statements, other than statements of historical facts, included herein are “forward-looking statements” including, among other things, statements about HeartSciences’ beliefs and expectations. These statements are based on current expectations, assumptions and uncertainties involving judgments about, among other things, future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond the Company’s control. The expectations reflected in these forward-looking statements involve significant assumptions, risks and uncertainties, and these expectations may prove to be incorrect. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Potential risks and uncertainties include, but are not limited to, risks discussed in HeartSciences’ filings with the U.S. Securities and Exchange Commission at www.sec.gov. Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements.

For Investor and Media Inquiries, please contact:

Advertisement

Investor Relations:
CoreIR
Email: [email protected]
Tel: 631-703-4900
Website: www.coreir.com

Company:
Gene Gephart
Phone: +1-737-414-9213 (US)
Email: [email protected] 

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

Eye Level holds its 2024 Eye Level Math Olympiad for students to test out their math skills.

Published

on

eye-level-holds-its-2024-eye-level-math-olympiad-for-students-to-test-out-their-math-skills.

SEOUL, South Korea, Oct. 17, 2024 /PRNewswire/ — Eye Level is hosting the 2024 Math Olympiad (ELMO 2024), inviting students from grades 1 to 8 worldwide to showcase their math skills. The competition will run from November 9 to December 1, following each country’s schedule across 15 countries.object

This Olympiad, part of the annual Eye Level Math Olympiad series established in 2004, offers students a valuable opportunity to assess and enhance their mathematical abilities. The test lasts approximately one hour and is designed to challenge students across various areas of math skills, covering most arithmetic and critical thinking domains. Questions are tailored to each grade level, allowing students to evaluate their skills objectively.All participants will receive a certificate of participation and a comprehensive analysis of their test results. Official results and winners will be announced in January 2025 on myeyelevel.com, with award ceremonies planned to be held locally for outstanding participants.
Registration is currently open on myeyelevel.com.
About Eye Level
Eye Level is an international provider of supplemental education services in Math and English with more than 2 million students having experienced its programs. Eye Level guides the students to learn at their own pace, and achieve their goals. With a growth-minded learning process, Eye Level helps students build good learning habits that become the foundation of great talent – setting them up for success in school and beyond. 
Photo – https://mma.prnewswire.com/media/2533165/p14_1_ELMO.jpg

View original content:https://www.prnewswire.co.uk/news-releases/eye-level-holds-its-2024-eye-level-math-olympiad-for-students-to-test-out-their-math-skills-302278994.html

Continue Reading

Artificial Intelligence

n2 Group Advances HPC/AI Portfolio by Acquiring Managed Services Company X-ISS

Published

on

n2-group-advances-hpc/ai-portfolio-by-acquiring-managed-services-company-x-iss

OXFORD, England, Oct. 17, 2024 /PRNewswire/ — n2 Group, the transformative computing technology investment company, announces the acquisition of high-performance computing (HPC) and AI specialists, X-ISS. The addition of X-ISS expands the Group’s portfolio– joining NAG, VSNi, BioTeam and STAC—as it accelerates advancements in technology and computation, underpinned by innovation, technical excellence, and a focus on long-term growth.

n2 Group invests selectively in technical computing companies with deep business impact in a variety of sectors, providing operational support and a collaborative approach to innovation and business transformation. The addition of X-ISS will further strengthen the Group’s already strong HPC/AI credentials, with NAG, STAC and BioTeam already adding to this space. 
X-ISS is a pioneer in Managed Services specifically designed for HPC/AI. With their in-depth understanding of hardware and software complexities within HPC and AI, they deliver highly impactful end-to-end services to clients through the integration, optimization and management of HPC/AI systems. The integration of X-ISS into n2 Group aligns with the Group vision of improving the accessibility, quality and robustness of computing solutions to enable greater productivity in industry. 
X-ISS will operate as an autonomous business within the n2 Group, maintaining its brand, identity and ethos. n2 Group’s status as an independent, member-backed organisation with no external financial stakeholders allows X-ISS to continue providing impartial advice based on the technology needs and challenges of its clients. Inter-group synergies will enable greater innovation and collaboration, advancing the Group’s position and long-term HPC/AI market impact. 
“X-ISS strengthens the n2 community in the strategically important area of HPC/AI”, said Adrian Scales, Snr Director of Investments and Partnerships at n2 Group. “As a respected boutique HPC service provider, X-ISS is helping clients navigate an increasingly complex landscape in terms of technologies and software integrations with AI and analytics. The acquisition strongly complements the Group’s existing HPC professional services capability, and we are delighted to have them on board.”
“This is an important milestone for X-ISS.”, said Deepak Khosla, CEO X-ISS, “The partnership with n2 Group will enable us to enhance our flagship ManagedHPC solution by leveraging n2’s complementary services and product developments, allowing us to deliver even greater value to our customers. As businesses face increasing challenges with complex technologies like AI and cloud computing, we’re now better equipped to support them with the same quality, passion, and partnership that defines X-ISS. I am excited about the opportunities this can bring for current and future X-ISS customers.”
About n2 Group  
At n2 Group we are transforming computing and technology investment with a radical new approach. Our businesses are all established, purpose-driven market-leaders in computing products or services. We stimulate long-term sustainable growth through group-level support in strategy, business development, innovation, and operations. With no shareholders or external financial interests, we reinvest all profits back into the group or to the community, reinforcing our commitment to positive social impact through technological advancements.    
n2 Group companies are at the forefront of computing and IT infrastructure, helping clients in various sectors to be more productive, innovative or reduce risk through advanced software and services. Rapidly expanding in high-performance computing, artificial intelligence, and scientific computing, our businesses maintain their unique brands and identities, but benefit from the expanded network available through the group.   
n2 Group Companies  
•  BioTeam: Scientific computing consultancy integrating technologies, data, and cultures to accelerate science. 
•  NAG: Advanced products and services in algorithms, optimization, high-performance computing and AI. 
•  STAC: Independent financial services technology research and community events. 
•  VSNi: Proven statistical solutions and data expertise driving innovation and success.  
•  X-ISS: Industry leading management and analytics solutions for HPC/AI systems.
For more detailed information and the latest updates, visit n2 Group. 
Logo – https://mma.prnewswire.com/media/2271328/n2_Group_Logo.jpgLogo –  https://mma.prnewswire.com/media/2533549/XISS_Logo.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/n2-group-advances-hpcai-portfolio-by-acquiring-managed-services-company-x-iss-302279433.html

Continue Reading

Artificial Intelligence

TIE 2024 Unveils a New Era of Innovation

Published

on

tie-2024-unveils-a-new-era-of-innovation

A New Era of AI-powered Innovation and Industrial Revolution: Driving Integration of Smart Tech into Daily Life.
TAIPEI, Oct. 17, 2024 /PRNewswire/ — The 2024 Taiwan Innotech Expo (TIE) kicked off today at Taipei World Trade Center with a focus on “Smart Tech Island –The New Era of AI.” This year’s event showcases over a thousand advanced technologies and research achievements across six key areas: digital information, data security, precision health, defense, green and renewable energy, and civil and military resilience, heralding a new chapter in the technological evolution of industries.

Online and On-Site Exhibitions Offers Comprehensive Access to the Latest Innovations
TIE 2024 offers a seamless blend of virtual and physical experiences. Visitors can explore technologies, register for events, and plan their visit online before the expo opens. During the expo period, the event website provides essential tools such as e-meeting requests, product maps, and program registration. For those who were unable to attend in person, online attendees can view exhibits and access business negotiation records even after the expo is closed, fostering ongoing collaboration and opportunities. As a leading platform for technological innovation exchanges in Taiwan, TIE 2024 showcases the nation’s advancements in AI and smart technologies. This event is anticipated to drive industry transformation and opens new chapters in technological innovation.
Official Website: https://tie.twtm.com.tw/en

View original content:https://www.prnewswire.co.uk/news-releases/tie-2024-unveils-a-new-era-of-innovation-302279310.html

Continue Reading
Advertisement
Advertisement

Latest News

Trending